Document is current
Any future updates will be listed below
-
Authors
Xie, Yuxin https://orcid.org/0009-0007-6659-5886
Zhao, Runlong
Zheng, Yingjiao https://orcid.org/0009-0007-7905-5547
Li, Yan https://orcid.org/0000-0002-5346-3098
Wu, Feng https://orcid.org/0000-0002-0570-4280
Lei, Yufei https://orcid.org/0009-0005-1486-8008
Li, Lei
Zeng, Hanqing https://orcid.org/0009-0004-2224-9920
Chen, Zhe https://orcid.org/0009-0001-6411-9065
- License Information
-
More Information
Article History
Received: 8 October 2024
Revised: 18 February 2025
Accepted: 3 March 2025
First Online: 13 March 2025
Competing interests
: The authors declare no competing interests.
: The authors affirm that all methods were conducted in accordance with the relevant guidelines and regulations. All mice were housed at the Animal Center of Chongqing Medical University, and approval was obtained from the Animal Committee of the Institute of Zoology at Chongqing Medical University (reference number: IACUC-CQMU-2024-0046, “The study on pathogenesis and targeted intervention of acute myeloid leukemia”). Whole BM samples were obtained from AML patients after informed consent of sample use for research. The use of human samples was approved by the Medical Ethics Committees of Chongqing Medical University (reference number: 2024019, “The study on pathogenesis and targeted intervention of acute myeloid leukemia”).
